HighVista Strategies »

Pharvaris N V shares owned by HighVista Strategies

Quarter-by-quarter ownership of Pharvaris N V (PHVS) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Pharvaris N V

Tip: Access up to 7 years of quarterly data

All positions including Pharvaris N V held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pharvaris N V by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2024-03-31 $387k 17k 23.11

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Apogee Therapeutics (APGE)
Spyre Therapeutics Com New (SYRE)
Merus N V (MRUS)
Microsoft Corporation (MSFT)
Arcellx Common Stock (ACLX)
Xpo Logistics Inc equity (XPO)
Nuvalent Inc-a (NUVL)
Ansys (ANSS)
Hess (HES)
Ideaya Biosciences (IDYA)
Juniper Networks (JNPR)
Sp Plus
Cerevel Therapeutics Hldng I (CERE)
Albertsons Cos Common Stock (ACI)

View all positions for HighVista Strategies

Top funds holding Pharvaris N V

General Atlantic
FMR
Foresite Capital Management IV
venBio Partners
Viking Global Investors
VR Adviser
Bain Capital Life Sciences Investors
Commodore Capital
Novo A/S
Cormorant Asset Management
Deerfield Management Company
EcoR1 Capital
5AM Venture Management
Rock Springs Capital Management
Sofinnova Ventures

View all funds holding Pharvaris N V